Showing 8,121 - 8,140 results of 35,226 for search '(( 50 ((mean decrease) OR (a decrease)) ) OR ( 5 ((point decrease) OR (nn decrease)) ))', query time: 1.11s Refine Results
  1. 8121

    Jatrophane Diterpenoids from <i>Euphorbia glomerulans</i> by Aobulikasimu Hasan (6448166)

    Published 2019
    “…Several compounds showed different chemoreversal activities and considerably decreased cytotoxicity. Compounds <b>11</b> (IC<sub>50</sub> value of 5.0 ± 0.8 μM) and <b>12</b> (IC<sub>50</sub> value of 5.2 ± 2.0 μM) possessed MDR reversal activities that were as good as that of verapamil (IC<sub>50</sub> value of 4.7 ± 0.6 μM).…”
  2. 8122

    Jatrophane Diterpenoids from <i>Euphorbia glomerulans</i> by Aobulikasimu Hasan (6448166)

    Published 2019
    “…Several compounds showed different chemoreversal activities and considerably decreased cytotoxicity. Compounds <b>11</b> (IC<sub>50</sub> value of 5.0 ± 0.8 μM) and <b>12</b> (IC<sub>50</sub> value of 5.2 ± 2.0 μM) possessed MDR reversal activities that were as good as that of verapamil (IC<sub>50</sub> value of 4.7 ± 0.6 μM).…”
  3. 8123

    Jatrophane Diterpenoids from <i>Euphorbia glomerulans</i> by Aobulikasimu Hasan (6448166)

    Published 2019
    “…Several compounds showed different chemoreversal activities and considerably decreased cytotoxicity. Compounds <b>11</b> (IC<sub>50</sub> value of 5.0 ± 0.8 μM) and <b>12</b> (IC<sub>50</sub> value of 5.2 ± 2.0 μM) possessed MDR reversal activities that were as good as that of verapamil (IC<sub>50</sub> value of 4.7 ± 0.6 μM).…”
  4. 8124
  5. 8125
  6. 8126
  7. 8127

    Extended exposure to extracellular adenosine (ADO) causes a dose-dependent reduction in chlamydial development via the A2b adenosine receptor. by Matthew A. Pettengill (256020)

    Published 2009
    “…(<b>B</b>) HeLa cell knock-downs (KDs) were produced with non-targeted (Control), A2a-targeted (A2a KD) or A2b-targeted (A2b KD) shRNA and levels of target KD verified to be decreased at least 50% by qPCR. …”
  8. 8128
  9. 8129
  10. 8130
  11. 8131
  12. 8132

    Expression profiling in APP23 mouse brain: inhibition of Aβ amyloidosis and inflammation in response to LXR agonist treatment-3 by Iliya Lefterov (73826)

    Published 2011
    “…Note that unlike in WT cells, GW does not decrease the expression of iNOS and IL-6 in dko cells. …”
  13. 8133
  14. 8134

    Viability of <i>MRE11</i>, <i>mre11A470T</i>, <i>rap1-5</i>, <i>and mre11A470T rap1-5</i>. by In-Joon Baek (4423057)

    Published 2017
    “…<i>mre11A470T</i> and <i>mre11A470T rap1-5</i> cells had decreased viability only at 37°C. …”
  15. 8135

    Defective STAT5 signalling in Gfi1<sup>−/−</sup> progenitor B cells. by Chozhavendan Rathinam (273627)

    Published 2007
    “…<p>A) Western blot analysis showing decreased STAT5 phosphorylation in B220<sup>+</sup> bone marrow cells upon IL7-signalling. …”
  16. 8136
  17. 8137

    TLR4 and RAGE were involved in HMGB1-induced activation of NF-κB in bEnd.3 cells. by Yan Chen (4308)

    Published 2015
    “…Inhibition of TLR4 and RAGE resulted in a significant decrease in HMGB1-induced NF-κB p65 translocation to nuclei. …”
  18. 8138
  19. 8139
  20. 8140